|
OMIM |
Link |
Information gain |
01 |
|
salivary substance, clostridium botulinum type
|
[NCBI]
|
0.00296772
|
|
|
duodenal ulcer, hyperpepsinogenemic i
|
[NCBI]
|
0.00211895
|
|
|
helicobacter pylori infection, susceptibility to
|
[NCBI]
|
0.000383704
|
|
|
FUT3
|
[NCBI]
|
0.000358888
|
|
|
FUT2
|
[NCBI]
|
0.00028215
|
|
|
blood group, p system
|
[NCBI]
|
0.000219568
|
|
|
blood group--abh antigen, type 2
|
[NCBI]
|
0.000182027
|
|
|
CEACAM5
|
[NCBI]
|
0.000157921
|
|
|
FUT1
|
[NCBI]
|
0.000129607
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
0.000120994
|
|
|
CF
|
[NCBI]
|
8.62589e-05
|
|
|
VWS
|
[NCBI]
|
8.31141e-05
|
|
|
ST3GAL4
|
[NCBI]
|
6.82806e-05
|
|
|
OCP
|
[NCBI]
|
6.58357e-05
|
|
|
FUT6
|
[NCBI]
|
6.46441e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
5.74974e-05
|
|
|
C3
|
[NCBI]
|
4.16691e-05
|
|
|
FUT5
|
[NCBI]
|
3.4101e-05
|
|
|
PCNA
|
[NCBI]
|
3.28792e-05
|
|
|
LW
|
[NCBI]
|
2.98542e-05
|
|
|
FUT4
|
[NCBI]
|
2.75228e-05
|
|
|
LU
|
[NCBI]
|
2.4313e-05
|
|
|
MBL2
|
[NCBI]
|
2.3109e-05
|
|
|
PGD
|
[NCBI]
|
2.30887e-05
|
|
|
GZMB
|
[NCBI]
|
2.12584e-05
|
|
|
TIMP1
|
[NCBI]
|
1.97543e-05
|
|
|
ACP1
|
[NCBI]
|
1.97543e-05
|
|
|
ABO
|
[NCBI]
|
1.93353e-05
|
|
|
UMOD
|
[NCBI]
|
1.71685e-05
|
|
|
JAK2
|
[NCBI]
|
1.03033e-05
|
|
|
ACPP
|
[NCBI]
|
7.23122e-06
|
|
|
MG
|
[NCBI]
|
7.12994e-06
|
|
|
ALB
|
[NCBI]
|
5.19518e-06
|
|
|
MUC1
|
[NCBI]
|
5.0522e-06
|
|
|
TNF
|
[NCBI]
|
4.42438e-06
|
|
|
VEGF
|
[NCBI]
|
3.813e-06
|
|
|
EGF
|
[NCBI]
|
3.61982e-06
|
|
|
TF
|
[NCBI]
|
3.60574e-06
|
|
|
EGFR
|
[NCBI]
|
1.31166e-06
|
|
|
AFP
|
[NCBI]
|
2.76181e-07
|
|
|
MPO
|
[NCBI]
|
1.6905e-07
|
|
|
RA
|
[NCBI]
|
3.14403e-08
|
|
|
GFAP
|
[NCBI]
|
2.52522e-08
|
|
|
KLK3
|
[NCBI]
|
8.96021e-09
|
|